Enteral stents in malignant bowel obstruction

Gastrointestinal Endoscopy Clinics of North America

Volumn 23, Issue 1, 2013, Pages 153-164

  Aadam, A Aziz ^a   Martin, John A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Colonic stent; Gastroduodenal stent; Malignant bowel obstruction; Self expanding metal stent

Indexed keywords

BEVACIZUMAB;

BLEEDING; COLORECTAL CANCER; COLORECTAL STENT; COMPUTER ASSISTED TOMOGRAPHY; FLUOROSCOPY; HEALTH CARE COST; HUMAN; INFECTION; INTESTINE ISCHEMIA; INTESTINE OBSTRUCTION; INTESTINE PERFORATION; MALIGNANT BOWEL OBSTRUCTION; META ANALYSIS (TOPIC); NUTRITIONAL STATUS; PALLIATIVE THERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECTUM CANCER; REVIEW; STENT; STOMACH ADENOCARCINOMA; SYSTEMATIC REVIEW (TOPIC); TENESMUS; TREATMENT INDICATION; UNITED STATES;

ENDOSCOPY, GASTROINTESTINAL; GASTROINTESTINAL NEOPLASMS; HUMANS; INTESTINAL OBSTRUCTION; PALLIATIVE CARE; POSTOPERATIVE COMPLICATIONS; STENTS; TREATMENT OUTCOME;

EID: 84869840165     PISSN: 10525157     EISSN: 15581950     Source Type: Journal    
DOI: 10.1016/j.giec.2012.10.006     Document Type: Review

References (49)

1. Dohmoto M., Rupp K.D., Hohlbach G. Dtsch Med Wochenschr 1990, 115:915. [in German].
2. Spinelli P., Dal Fante M., Mancini A. Self-expanding mesh stent for endoscopic palliation of rectal obstructing tumors: a preliminary report. Surg Endosc 1992, 6:72-74.
3. Duerig T.P., Pelton A., Stockel D. An overview of nitinol medical applications. Mater Sci Eng A-structural Materials Properties Microst 1999, 275:149-160.
4. Lillemoe K.D., Pitt H.A. Palliation. Surgical and otherwise. Cancer 1996, 78:605-614.
5. Sohn T.A., Lillemoe K.D., Cameron J.L., et al. Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 1999, 188:658-666. [discussion: 66-9].
6. Bozzetti F., Bonfanti G., Audisio R.A., et al. Prognosis of patients after palliative surgical procedures for carcinoma of the stomach. Surg Gynecol Obstet 1987, 164:151-154.
7. Weaver D.W., Wiencek R.G., Bouwman D.L., et al. Gastrojejunostomy: is it helpful for patients with pancreatic cancer?. Surgery 1987, 102:608-613.
8. van Hooft J.E., Dijkgraaf M.G., Timmer R., et al. Independent predictors of survival in patients with incurable malignant gastric outlet obstruction: a multicenter prospective observational study. Scand J Gastroenterol 2010, 45:1217-1222.
9. Jeurnink S.M., van Eijck C.H., Steyerberg E.W., et al. Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol 2007, 7:18.
10. Jeurnink S.M., Steyerberg E.W., van Hooft J.E., et al. Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc 2010, 71:490-499.
11. Jeurnink S.M., Polinder S., Steyerberg E.W., et al. Cost comparison of gastrojejunostomy versus duodenal stent placement for malignant gastric outlet obstruction. J Gastroenterol 2010, 45:537-543.
12. Zheng B., Wang X., Ma B., et al. Endoscopic stenting versus gastrojejunostomy for palliation of malignant gastric outlet obstruction. Dig Endosc 2012, 24:71-78.
13. Dormann A., Meisner S., Verin N., et al. Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 2004, 36:543-550.
14. Costamagna G., Tringali A., Spicak J., et al. Treatment of malignant gastroduodenal obstruction with a nitinol self-expanding metal stent: an international prospective multicentre registry. Dig Liver Dis 2012, 44:37-43.
15. Homs M.Y., Steyerberg E.W., Kuipers E.J., et al. Causes and treatment of recurrent dysphagia after self-expanding metal stent placement for palliation of esophageal carcinoma. Endoscopy 2004, 36:880-886.
16. Park J.C., Park J.J., Cheoi K., et al. Clinical outcomes of secondary stent-in-stent self-expanding metal stent placement for primary stent malfunction in malignant gastric outlet obstruction. Dig Liver Dis 2012, 44(12):999-1005.
17. Kim J.H., Song H.Y., Shin J.H., et al. Metallic stent placement in the palliative treatment of malignant gastroduodenal obstructions: prospective evaluation of results and factors influencing outcome in 213 patients. Gastrointest Endosc 2007, 66:256-264.
18. Telford J.J., Carr-Locke D.L., Baron T.H., et al. Palliation of patients with malignant gastric outlet obstruction with the enteral Wallstent: outcomes from a multicenter study. Gastrointest Endosc 2004, 60:916-920.
19. Cho Y.K., Kim S.W., Hur W.H., et al. Clinical outcomes of self-expandable metal stent and prognostic factors for stent patency in gastric outlet obstruction caused by gastric cancer. Dig Dis Sci 2010, 55:668-674.
20. Kim C.G., Park S.R., Choi I.J., et al. Effect of chemotherapy on the outcome of self-expandable metallic stents in gastric cancer patients with malignant outlet obstruction. Endoscopy 2012, 44:807-812.
21. Deans G.T., Krukowski Z.H., Irwin S.T. Malignant obstruction of the left colon. Br J Surg 1994, 81:1270-1276.
22. Rault A., Collet D., Sa Cunha A., et al. Ann Chir 2005, 130:331-335. [in French].
23. Tekkis P.P., Kinsman R., Thompson M.R., et al. The Association of Coloproctology of Great Britain and Ireland study of large bowel obstruction caused by colorectal cancer. Ann Surg 2004, 240:76-81.
24. Finan P.J., Campbell S., Verma R., et al. The management of malignant large bowel obstruction: ACPGBI position statement. Colorectal Dis 2007, 9(Suppl 4):1-17.
25. Sjo O.H., Larsen S., Lunde O.C., et al. Short term outcome after emergency and elective surgery for colon cancer. Colorectal Dis 2009, 11:733-739.
26. Villar J.M., Martinez A.P., Villegas M.T., et al. Surgical options for malignant left-sided colonic obstruction. Surg Today 2005, 35:275-281.
27. Pearce N.W., Scott S.D., Karran S.J. Timing and method of reversal of Hartmann's procedure. Br J Surg 1992, 79:839-841.
28. Desai D.C., Brennan E.J., Reilly J.F., et al. The utility of the Hartmann procedure. Am J Surg 1998, 175:152-154.
29. Koruth N.M., Krukowski Z.H., Youngson G.G., et al. Intra-operative colonic irrigation in the management of left-sided large bowel emergencies. Br J Surg 1985, 72:708-711.
30. Kingham T.P., Pachter H.L. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg 2009, 208:269-278.
31. Park I.J., Choi G.S., Kang B.M., et al. Comparison of one-stage managements of obstructing left-sided colon and rectal cancer: stent-laparoscopic approach vs. intraoperative colonic lavage. J Gastrointest Surg 2009, 13:960-965.
32. Fast stats: an interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. Available at: . Accessed August 28, 2012. http://seer.cancer.gov/faststats.
33. Watt A.M., Faragher I.G., Griffin T.T., et al. Self-expanding metallic stents for relieving malignant colorectal obstruction: a systematic review. Ann Surg 2007, 246:24-30.
34. Alcantara M., Serra-Aracil X., Falco J., et al. Prospective, controlled, randomized study of intraoperative colonic lavage versus stent placement in obstructive left-sided colonic cancer. World J Surg 2011, 35:1904-1910.
35. Cheung H.Y., Chung C.C., Tsang W.W., et al. Endolaparoscopic approach vs conventional open surgery in the treatment of obstructing left-sided colon cancer: a randomized controlled trial. Arch Surg 2009, 144:1127-1132.
36. Pirlet I.A., Slim K., Kwiatkowski F., et al. Emergency preoperative stenting versus surgery for acute left-sided malignant colonic obstruction: a multicenter randomized controlled trial. Surg Endosc 2011, 25:1814-1821.
37. van Hooft J.E., Bemelman W.A., Oldenburg B., et al. Colonic stenting versus emergency surgery for acute left-sided malignant colonic obstruction: a multicentre randomised trial. Lancet Oncol 2011, 12:344-352.
38. Tan C.J., Dasari B.V., Gardiner K. Systematic review and meta-analysis of randomized clinical trials of self-expanding metallic stents as a bridge to surgery versus emergency surgery for malignant left-sided large bowel obstruction. Br J Surg 2012, 99:469-476.
39. Sebastian S., Johnston S., Geoghegan T., et al. Pooled analysis of the efficacy and safety of self-expanding metal stenting in malignant colorectal obstruction. Am J Gastroenterol 2004, 99:2051-2057.
40. Sagar J. Colorectal stents for the management of malignant colonic obstructions. Cochrane Database Syst Rev 2011, (11). CD007378.
41. Song L.M., Baron T.H. Stenting for acute malignant colonic obstruction: a bridge to nowhere?. Lancet Oncol 2011, 12:314-315.
42. Lee W.S., Baek J.H., Kang J.M., et al. The outcome after stent placement or surgery as the initial treatment for obstructive primary tumor in patients with stage IV colon cancer. Am J Surg 2012, 203:715-719.
43. Manes G., de Bellis M., Fuccio L., et al. Endoscopic palliation in patients with incurable malignant colorectal obstruction by means of self-expanding metal stent: analysis of results and predictors of outcomes in a large multicenter series. Arch Surg 2011, 146:1157-1162.
44. Lee H.J., Hong S.P., Cheon J.H., et al. Long-term outcome of palliative therapy for malignant colorectal obstruction in patients with unresectable metastatic colorectal cancers: endoscopic stenting versus surgery. Gastrointest Endosc 2011, 73:535-542.
45. Small A.J., Coelho-Prabhu N., Baron T.H. Endoscopic placement of self-expandable metal stents for malignant colonic obstruction: long-term outcomes and complication factors. Gastrointest Endosc 2010, 71:560-572.
46. van Hooft J.E., Fockens P., Marinelli A.W., et al. Early closure of a multicenter randomized clinical trial of endoscopic stenting versus surgery for stage IV left-sided colorectal cancer. Endoscopy 2008, 40:184-191.
47. Datye A., Hersh J. Colonic perforation after stent placement for malignant colorectal obstruction-causes and contributing factors. Minim Invasive Ther Allied Technol 2011, 20:133-140.
48. Cennamo V., Fuccio L., Mutri V., et al. Does stent placement for advanced colon cancer increase the risk of perforation during bevacizumab-based therapy?. Clin Gastroenterol Hepatol 2009, 7:1174-1176.
49. Hapani S., Chu D., Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol 2009, 10:559-568.